Figure 6
Figure 6. Pretreatment with olaparib sensitizes ATM null cells to cytotoxic agents. (A) Effect of 1μM olaparib on killing by 12.5μM bendamustine, 0.1μM fludarabine, 0.1μM 4HC, 5mM VPA, and 1 Gy IR in ATM mutant Granta-519 cells. Synergistic effects (see supplemental Table 2) for the given doses are shown below the graph (+++ synergism; ++ moderate synergism; + slight synergism; ± nearly additive). (B) Western blot analysis of Granta-519 cells showing an increased cleavage of PARP1, caspase 7, and caspase 3 after combined olaparib plus 4HC, VPA, or IR treatment compared with treatment with 4HC, VPA, or IR alone. Actin shows equal loading.

Pretreatment with olaparib sensitizes ATM null cells to cytotoxic agents. (A) Effect of 1μM olaparib on killing by 12.5μM bendamustine, 0.1μM fludarabine, 0.1μM 4HC, 5mM VPA, and 1 Gy IR in ATM mutant Granta-519 cells. Synergistic effects (see supplemental Table 2) for the given doses are shown below the graph (+++ synergism; ++ moderate synergism; + slight synergism; ± nearly additive). (B) Western blot analysis of Granta-519 cells showing an increased cleavage of PARP1, caspase 7, and caspase 3 after combined olaparib plus 4HC, VPA, or IR treatment compared with treatment with 4HC, VPA, or IR alone. Actin shows equal loading.

Close Modal

or Create an Account

Close Modal
Close Modal